Navigation Links
Beaumont holds first international congress on underactive bladder
Date:2/19/2014

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

Beaumont Health System urologists hope to heighten awareness of underactive bladder, or UAB, through an international forum funded in part by the National Institutes of Health. The Feb. 20-21 Congress of Urologic Research and Education on Aging Underactive Bladder, orCURE-UAB, in Bethesda, Md., is attracting physicians, researchers and nurses from around the world for scientific discussion and interdisciplinary collaboration.

Underactive bladder syndrome is a chronic, complex and debilitating disease affecting a person's ability to empty their bladder. Those with an underactive bladder can hold unusually large amounts of urine but have a diminished sense of when the bladder is full and are not able to contract the muscles sufficiently or forcefully enough to empty the bladder.

Symptoms and severity of the condition can vary. Some with UAB must use a strawcatheter several times a day to empty their bladder. This puts them at risk of developing catheter-associated infections. Others have indwelling catheters, left in place for a period of time, or undergo surgical procedures to relieve UAB symptoms.

UAB is primarily associated with aging, diabetes, and neurological diseases, and itis a major cause of nursing home admissions. Currently, no medications or therapies have proven effective in the long-term treatment of UAB and no known cure exists. UAB can also lead to other conditions such as urinary tract infections, bladder stones, or, in severe cases, kidney damage. The emotional effects of the disease can be devastating‒causing embarrassment, and diminishing both quality of life and independence.

"CURE-UAB is the first meeting dedicated to discussion of underactive bladder and features a world-renowned faculty," says Michael Chancellor, M.D., director, neuro-urology, Beaumont Health System. "Our goal is to bring the world's top clinicians and researchers together to collaborate and promote advancement of underactive bladder research and education"

Physicians and researchers from as far away as Australia, Japan, and India are expected to attend.

At the forum, Beaumont researchers will present the results of the first population-based research of underactive bladder syndrome. Twenty-three percent of the 633 respondents in Metro Detroit reported having a problem emptying the bladder completely, yet only 11 percent had ever heard of UAB. Those reporting UAB symptoms were twice as likely to describe their health as "poor" or "fair" compared to other respondents. The results suggest that the burden and impact of UAB are significant.

Dr. Chancellor will discuss novel therapies for treating UAB, including stem cell and gene therapy. The world's first stem cell treatment for UAB was performed at Beaumont last September.


'/>"/>

Contact: Angela Blazevski
angela.blazevski@beaumont.edu
248-551-0445
Beaumont Health System
Source:Eurekalert

Related medicine news :

1. Beaumont Health System first outside of Japan to test new atrial fibrillation technology
2. Beaumont Health System Research: Accelerated Breast Radiation Treatment Provides Same Outcomes after 10 Years
3. Victory Medical Center Beaumont Celebrates 1000th Surgery
4. Beaumont, Royal Oak repeats as Consumer Choice Award winner for 18th time
5. Beaumont Health System Launches Research Trial of Bioresorbable Heart Scaffold
6. Beaumont Health System launches research trial of bioresorbable heart scaffold
7. Beaumont Study: Nerve Stimulation Helps with Overactive Bladder
8. Beaumont Health System Recognized as an American Heart Association Fit-Friendly Worksite
9. Beaumont Cardiologist Kavitha Chinnaiyan, M.D., Receives Excellence in Research Award
10. Beaumont cardiologist Kavitha Chinnaiyan, M.D., receives excellence in research award
11. Beaumont receives national green award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... ... announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies ... quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known as ... kidneys, liver and pancreas. If not properly addressed, visceral fat can lead to ... Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral fat. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... , ... May 02, 2016 , ... Pregnancy Awareness Month ... trying to conceive. , “If you are ready to have a baby, ... “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, written ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... and urgent care facilities designed to automate and improve the rapid diagnosis, triage ... it is demonstrating their platform, application, and mobile experience for the first time ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology: